Reaction

Neurodermatitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,439 reports · 29 co-occurring drugs

As of the last recalculation, Neurodermatitis appears in 3,439 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is NEMOLIZUMAB-ILTO (PRR 140.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Nemolizumab-Ilto272140.6143.6
Dupilumab2,35691.892.3
Hydroxyzine Hydrochloride3415.815.8
Hydroxyzine Hydrochloride Oral3415.815.8
Clobetasol Propionate Ointment Usp, 0.05%1810.610.6
Clobetasol Propionate1810.610.6
Triamcinolone Acetonide Ointment Usp, 0.05%3910.210.2
Mupirocin209.09.0
Mupirocin Calcium208.98.9
Hydroxyzine648.38.3
Triamcinolone Acetonide397.77.7
Doxepin Hydrochloride146.76.7
Crisaborole95.75.7
Cetirizine Hcl85.35.3
Doxepin84.84.8
Tretinoin64.54.5
Ketoconazole Foam104.14.1
Ketoconazole Cream, 2%104.14.1
Buspirone Hydrochloride73.83.8
Ritonavir 100 Mg93.73.7
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate203.43.4
Fexofenadine Hydrochloride123.33.4
Pertuzumab132.92.9
Blinatumomab42.32.3
Ocrelizumab222.22.2
Minoxidil Foam 5% (Womens)81.51.5
Galcanezumab-Gnlm61.21.2
Minoxidil81.11.1
Adapalene30.10.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.